MARKET

ITCI

ITCI

INTRA CELLULAR
NASDAQ

Real-time Quotes | Nasdaq Last Sale

9.15
-0.63
-6.44%
Closed 17:50 09/17 EDT
OPEN
9.76
PREV CLOSE
9.78
HIGH
9.82
LOW
9.12
VOLUME
1.16M
TURNOVER
--
52 WEEK HIGH
23.62
52 WEEK LOW
7.41
MARKET CAP
504.83M
P/E (TTM)
-3.2513
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ITCI and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 9 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ITCI News

  • Intra-Cellular files $350M mixed shelf
  • seekingalpha.5d ago
  • Intra-Cellular Therapies Files For Up To $75M Common Stock Offering
  • Benzinga.5d ago
  • Intra-Cellular Therapies Director Alafi Buys 485,000 @ Avg Price: $10.26
  • Benzinga.6d ago
  • Intra-Cellular provides lumateperone update; shares up 6% premarket
  • seekingalpha.09/10 17:02

More

Industry

Biotechnology & Medical Research
+0.26%
Pharmaceuticals & Medical Research
+0.57%

Hot Stocks

Name
Price
%Change

About ITCI

Intra-Cellular Therapies, Inc. (ITI) is a biopharmaceutical company. The Company is focused on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system (CNS). The Company is discovering and developing drugs for the treatment of neurological and psychiatric disorders. Lumateperone (also known as ITI-007) is its lead product candidate. The Company's bipolar depression program consists of two Phase III multi-center, randomized, double-blind, placebo-controlled clinical trials: one to evaluate lumateperone as a monotherapy and the other to evaluate lumateperone as an adjunctive therapy with lithium or valproate. The Company initiated Phase III development of lumateperone for the treatment of agitation in patients with dementia, including Alzheimer's Disease (AD).
More

Webull offers Intra-Cellular Therapies Inc (ITCI) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.